Why Gilead Sciences (GILD) Deserves Attention in the Cheap Quarterly Dividend Stocks Category

Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 11 Cheap Quarterly Dividend Stocks to Buy Right Now.

Gilead Sciences, Inc. (NASDAQ:GILD) is a California-based biopharmaceutical company that offers a wide range of products and services to its consumers. The biotech company develops innovative treatments for viral hepatitis, COVID-19, and cancer, while maintaining a strong pipeline of new drugs expected to support future sales growth. Gilead regularly strengthens its portfolio through acquisitions of early-stage drugmakers, such as its $350 million agreement to acquire Interius BioTherapeutics in August 2025.

Gilead Sciences, Inc. (NASDAQ:GILD) is also known for paying one of the more appealing dividends in the biotech industry. Since launching its dividend in 2015, the company has raised it every year. Its well-established HIV franchise continues to serve as the foundation of its business.

Currently, Gilead Sciences, Inc. (NASDAQ:GILD) offers a quarterly dividend of $0.79 per share and has a dividend yield of 2.76%, as of September 23.

While we acknowledge the potential of GILD as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Safest Monthly Dividend Stocks to Buy and Dividend Stock Portfolio For Retirement: 10 Stocks to Buy

Disclosure: None.